Cleveland BioLabs (CBLI)
Cleveland BioLabs Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -6.399M | -7.736M | -2.879M | 11.13M | -5.745M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.1274M | 0.1874M | 0.1149M | 0.1128M | 0.1104M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | -0.614M | 2.254M | -4.548M | -13.49M | 1.638M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | -0.4866M | 2.441M | -4.434M | -13.38M | 1.748M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | 2.091M | -1.001M | 1.773M | -1.983M | 3.155M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -4.794M | -6.296M | -5.539M | -4.228M | -0.8422M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.0816M | -0.1475M | -0.2391M | -0.101M | -0.168M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -5.493M | 0.6215M | 1.228M | -1.442M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Investing Activities | 0.30M | -0.30M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -0.0816M | -5.344M | 0.0825M | 0.9251M | -1.730M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -0.005M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Equity Issued | 0.0014M | -0.9445M | -1.573M | 23.80M | 1.199M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | 9.950M | 1.578M | -1.546M | 2.309M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Cash from Financing Activities | -0.0035M | 9.005M | 0.0049M | 22.25M | 3.508M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.1184M | 0.2472M | -0.2845M | 0.0295M | 0.1647M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -4.761M | -2.387M | -5.736M | 18.98M | 1.100M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 22.87M | 10.92M | 22.87M | 25.26M | 31.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 18.11M | 22.87M | 25.26M | 31.00M | 12.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
